THE ASAHI SHIMBUN
September 21, 2023 at 17:20 JST
BEIJING--A veteran employee of a Japanese pharmaceutical company has been criminally detained in China on suspicion of espionage, awaiting formal charges.
According to diplomatic sources, the male employee of Astellas Pharma Inc. who was initially detained in March as a suspected spy, has now been placed in “criminal detention.”
That means that Chinese authorities will likely decide soon whether he will be officially placed under arrest.
In Tokyo on Sept. 21, Chief Cabinet Secretary Hirokazu Matsuno said the government would continue to negotiate with Chinese officials for the early release of the male employee.
Government sources said Japanese Embassy officials who met the man found him to be in good health.
The detained man has worked in China for about 20 years and is well-known among the Japanese business community in Beijing. He had an extensive network of contacts in China, including important government officials, centered on the pharmaceutical industry.
He was detained in March shortly before he was scheduled to return to Japan, and the Chinese Foreign Ministry later announced that the man was being held as a suspected spy.
When then Foreign Minister Yoshimasa Hayashi visited Beijing in April, he asked that the man be released as soon as possible.
This request was ignored.
Japanese officials were informed in mid-September that the man has now been placed under criminal detention, and that a decision on whether to formally arrest him will likely be made within 37 days.
Even though he has already been detained for more than six months, a formal arrest could extend his detention considerably, particularly if he is subsequently indicted for espionage and faces court proceedings.
Japanese nationals working in China have become increasingly concerned about the uncertainties surrounding what constitutes spying in the eyes of the Chinese government.
If this man does go through the criminal process, Japanese and Western companies could re-evaluate their plans for entering the Chinese market.
(This article was compiled from reports by Sotaro Hata in Beijing and Shohei Sasagawa.)
Japanese man detained in China reported to be in good health
April 5, 2023
Hayashi visit shows uncertain future for Japan-China relations
April 3, 2023
Japan calls for swift release of detainee during key China talks
April 2, 2023
Hayashi to visit China amid friction over detained Japanese
March 31, 2023
EDITORIAL: Problem with anti-espionage law in China is that it is opaque
March 29, 2023
Latest detention in China source of major concern for Japan expats
March 28, 2023
Stories about memories of cherry blossoms solicited from readers
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series on the death of a Japanese woman that sparked a debate about criminal justice policy in the United States
A series about Japanese-Americans and their memories of World War II
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
The head office of Astellas Pharma Inc. located in Tokyo's Chuo Ward (Asahi Shimbun file photo)
